Novocastratm Lyophilized Mouse Monoclonal Antibody Dysferlin
Novocastratm Lyophilized Mouse Monoclonal Antibody Dysferlin
Novocastratm Lyophilized Mouse Monoclonal Antibody Dysferlin
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Vævsfarvning er afhængig af håndteringen og behandlingen af vævet inden farvning. Forkert fiksering, frysning, optøning, vask, tørring,<br />
opvarmning, sektionering eller kontaminering med andet væv eller andre væsker kan frembringe artefakter, indfangning af antistof<br />
eller falske negative resultater. Inkonsistente resultater kan skyldes variationer i fikserings- og indstøbningsmetoder eller irregulariteter<br />
indeholdt i vævet. 4<br />
For kraftig eller ukomplet kontrastfarvning kan gøre korrekt fortolkning af resultaterne vanskelig.<br />
Klinisk fortolkning af farvning eller mangel derpå skal suppleres med morfologiske undersøgelser under anvendelse af passende<br />
kontroller og bør evalueres i sammenhæng med patientens kliniske historie og andre diagnostiske tests af en kvalificeret patolog.<br />
Antistoffer fra Leica Biosystems Newcastle Ltd er som angivet beregnet til anvendelse på enten frosne eller paraffinindstøbte vævssnit<br />
med specifikke krav til fiksering. Der kan forekomme uventet antigenekspression, navnlig i neoplasmer. Den kliniske fortolkning af alle<br />
farvede vævssnit skal indbefatte morfologisk analyse og evaluering af passende kontroller.<br />
Bibliografi - Generelt<br />
1. National Committee for Clinical Laboratory Standards (NCCLS). Protection of laboratory workers from infectious diseases transmitted<br />
by blood and tissue; proposed guideline. Villanova, P.A. 1991;7(9). Order code M29-P.<br />
2. Battifora H. Diagnostic uses of antibodies to keratins: a review and immunohistochemical comparison of seven monoclonal and<br />
three polyclonal antibodies. Progress in Surgical Pathology. 6:1–15. eds. Fenoglio-Preiser C, Wolff CM, Rilke F. Field & Wood, Inc.,<br />
Philadelphia.<br />
3. Nadji M, Morales AR. Immunoperoxidase, part I: the techniques and pitfalls. Laboratory Medicine. 1983; 14:767.<br />
4. Omata M, Liew CT, Ashcavai M, Peters RL. Nonimmunologic binding of horseradish peroxidase to hepatitis B surface antigen: a<br />
possible source of error in immunohistochemistry. American Journal of Clinical Pathology. 1980; 73:626.<br />
5. Mahjneh I, Marconi G, Bushby K, et al. <strong>Dysferlin</strong>opathy (LGMD2B): a 23-year follow-up study of 10 patients homozygous for the<br />
same frameshifting dysferlin mutations. Neuromuscular Disorders. 2001; 11:20–26.<br />
6. Pollitt C, Anderson LVB, Pogue R et al. The phenotype of calpainopathy: diagnosis based on a multidisciplinary approach.<br />
Neuromuscular Disorders. 2001; 11(3):287–296.<br />
7. Anderson LVB, Harrison RM, Pogue R et al. Secondary reduction in calpain 3 expression in patients with limb girdle muscular<br />
dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscular Disorders. 2000; 10(8):553–559.<br />
8. Bornemann A and Anderson LVB. Diagnostic protein expression in human muscle biopsies. Brain Pathology. 2000; 10:193–214.<br />
9. Anderson LVB. Immunomarkers for molecular mass. Neuromuscular Disorders. 1999; 9(6-7):421–422.<br />
10. Anderson LVB, Davison K, Moss JA, et al. <strong>Dysferlin</strong> is a plasma membrane protein and is expressed early in human development.<br />
Human Molecular Genetics. 1999; 8(5):855–861.<br />
11. Bittner RE, Anderson LVB, Burkhardt E, et al. <strong>Dysferlin</strong> deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle<br />
muscular dystrophy 2B. Nature Genetics. 1999; 23:141–142.<br />
12. Weiler T, Bashir R, Anderson LVB, et al. Identical mutation in patients with limb girdle muscle dystrophy type 2B or Miyoshi myopathy<br />
suggests a role for modifier gene(s). Human Molecular Genetics. 1999; 8(5):871–877.<br />
13. Matsuda C, Hayashi YK, Ogawa M, et al. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Human<br />
Molecular Genetics. 2001; 10(17):1761–1766.<br />
Rettelser Til Tidligere Udgave<br />
Ingen rettelser.<br />
Udgivelsesdato<br />
18 Juni 2008 (NCL-Hamlet/CE/UK)<br />
NCL-Hamlet<br />
Page 51